REMINDER: Our user survey closes TODAY, please submit your responses here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksOsirium Tech Regulatory News (OSI)

  • This share is currently suspended. It was suspended at a price of 2.20

Share Price Information for Osirium Tech (OSI)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 2.20
Bid: 0.00
Ask: 0.00
Change: 0.00 (0.00%)
Spread: 0.00 (0.00%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 0.00
OSI Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Total Voting Rights

30 Nov 2022 07:00

RNS Number : 9835H
Osirium Technologies PLC
30 November 2022
 

30 November 2022

 

Osirium Technologies plc

("Osirium" or the "Company")

 

Total Voting Rights

 

Osirium Technologies plc (AIM: OSI), a leading vendor of cloud-based cybersecurity software, announces that the Company's issued ordinary share capital as at the date of this announcement comprises 55,258,381 ordinary shares of 1 pence each, with one voting right each. The Company does not hold any ordinary shares in treasury. Therefore, the total number of ordinary shares and voting rights in the Company is 55,258,381.

 

The above figure may be used by shareholders in the Company as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, the share capital of the Company under the FCA's Disclosure Guidance and Transparency Rules.

 

 

Contacts:

Osirium Technologies plc

Tel: +44 (0)1183 242 444

David Guyatt, CEO

Rupert Hutton, CFO

Allenby Capital Limited (Nominated adviser and broker)

Tel: +44 (0)20 3328 5656

James Reeve / George Payne (Corporate Finance)

Tony Quirke (Sales and Corporate Broking)

Alma PR (Financial PR adviser)

Tel: +44 (0)20 3405 0205

Hilary Buchanan

osirium@almapr.co.uk

Kieran Breheny

Will Ellis Hancock

 

 

About Osirium Technologies Plc

 

Osirium Technologies plc (AIM: OSI) is a leading UK-based cybersecurity software vendor delivering Privileged Access Management (PAM), Privileged Endpoint Management (PEM) and Osirium Automation solutions that are uniquely simple to deploy and maintain. 

 

With privileged credentials involved in over 80% of security breaches, customers rely on Osirium PAM's innovative technology to secure their critical infrastructure by controlling 3rd party access, protecting against insider threats, and demonstrating rigorous compliance. Osirium Automation delivers time and cost savings by automating complex, multi-system processes securely, allowing them to be delegated to Help Desk engineers or end-users and to free up specialist IT resources. The Osirium PEM solution balances security and productivity by removing risky local administrator rights from users, while at the same time allowing escalated privileges for specific applications.

 

Founded in 2008 and with its headquarters in Reading, UK, the Company's shares were admitted to trading on AIM in April 2016. For further information please visit www.osirium.com.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TVREAKFNASPAFFA
Date   Source Headline
1st Nov 202211:00 amRNSPrice Monitoring Extension
1st Nov 20227:00 amRNSQ3 2022 trading update
23rd Sep 202211:06 amRNSSecond Price Monitoring Extn
23rd Sep 202211:00 amRNSPrice Monitoring Extension
22nd Sep 20222:05 pmRNSSecond Price Monitoring Extn
22nd Sep 20222:00 pmRNSPrice Monitoring Extension
22nd Sep 20227:00 amRNSInterim Results
20th Sep 20227:00 amRNSSignificant contract extension
12th Sep 20227:00 amRNSNotice of Results
3rd Aug 20227:00 amRNSSignificant contract extension
21st Jul 20227:00 amRNSContract Win
8th Jul 20227:00 amRNSTrading Update
8th Jun 20224:40 pmRNSSecond Price Monitoring Extn
8th Jun 20224:35 pmRNSPrice Monitoring Extension
7th Jun 20221:02 pmRNSResult of AGM
30th May 20227:00 amRNSContract win for PEM solution
17th May 20227:00 amRNSFirst contract win in the United States
11th May 20227:00 amRNSReport and Accounts and Notice of AGM
5th May 20224:41 pmRNSSecond Price Monitoring Extn
5th May 20224:36 pmRNSPrice Monitoring Extension
27th Apr 20224:41 pmRNSSecond Price Monitoring Extn
27th Apr 20224:36 pmRNSPrice Monitoring Extension
25th Apr 20224:41 pmRNSSecond Price Monitoring Extn
25th Apr 20224:35 pmRNSPrice Monitoring Extension
21st Apr 202211:05 amRNSSecond Price Monitoring Extn
21st Apr 202211:00 amRNSPrice Monitoring Extension
21st Apr 20227:00 amRNSFinal Results
8th Apr 20222:06 pmRNSSecond Price Monitoring Extn
8th Apr 20222:00 pmRNSPrice Monitoring Extension
7th Apr 20222:05 pmRNSSecond Price Monitoring Extn
7th Apr 20222:00 pmRNSPrice Monitoring Extension
7th Apr 20229:00 amRNSPrice Monitoring Extension
6th Apr 20222:06 pmRNSSecond Price Monitoring Extn
6th Apr 20222:01 pmRNSPrice Monitoring Extension
6th Apr 202211:05 amRNSSecond Price Monitoring Extn
6th Apr 202211:00 amRNSPrice Monitoring Extension
5th Apr 20224:41 pmRNSSecond Price Monitoring Extn
5th Apr 20224:36 pmRNSPrice Monitoring Extension
5th Apr 20222:06 pmRNSSecond Price Monitoring Extn
5th Apr 20222:00 pmRNSPrice Monitoring Extension
5th Apr 202211:05 amRNSSecond Price Monitoring Extn
5th Apr 202211:00 amRNSPrice Monitoring Extension
5th Apr 20227:00 amRNSQ1 2022 Trading Update
1st Apr 20224:57 pmRNSHolding(s) in Company
31st Mar 20225:00 pmRNSTotal Voting Rights
25th Mar 20222:05 pmRNSSecond Price Monitoring Extn
25th Mar 20222:00 pmRNSPrice Monitoring Extension
24th Mar 20222:05 pmRNSSecond Price Monitoring Extn
24th Mar 20222:00 pmRNSPrice Monitoring Extension
24th Mar 20227:00 amRNSContract win for Privileged Process Automation

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.